1. Yang J, Ma J, Jin Y, Cheng S, Huang S, Wang Y. Dietary Inflammatory Index and Ovarian Cancer Risk: A Meta-Analysis. Nutr Cancer. 2021;1-10.
2. Yang J, Ma J, Jin Y, et al. Development and validation for prognostic nomogram of epithelial ovarian cancer recurrence based on circulating tumor cells and epithelial-mesenchymal transition. Sci Rep. 2021;11(1):6540.
3. Ma J, Yang J, Jin Y, et al. Artificial Intelligence Based on Blood Biomarkers Including CTCs Predicts Outcomes in Epithelial Ovarian Cancer: A Prospective Study. Onco Targets Ther. 2021;14:3267-3280.
4. Yang J, Huang S, Cheng S, Jin Y, Zhang N, Wang Y. Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current Opportunities. Front Cell Dev Biol. 2021;9:701429.
5.Zhang M, Cheng S, Jin Y, et al. Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics. [J] .2021. 11(2):e292
6.Zhang M, Cheng S, Jin Y, et al. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer. [J]. Biochim Biophys Acta Rev Cancer.2021. 7;1875(2):188503.
7.Zhang Nan, Jin Yue, Hu Qiubo et al. Circular RNA hsa_circ_0078607 suppresses ovarian cancer progression by regulating miR-518a-5p/Fas signaling pathway. [J] .J Ovarian Res, 2020, 13: 64.
8.Yang J, Ma J, Cheng S, Wang Y. The Combination of Plasma Fibrinogen Concentration and Neutrophil Lymphocyte Ratio (F-NLR) as a Prognostic Factor of Epithelial Ovarian Cancer. Onco Targets Ther. 2020;13:7283-7293.
9.Cheng Shanshan, Xu Cong, Jin Yue et al. Artificial Mini Dendritic Cells Boost T Cell-Based Immunotherapy for Ovarian Cancer. [J] .Adv Sci (Weinh), 2020, 7: 1903301.
10.Li Yuan, Yang Jia-Ni, Cheng Shan-Shan et al. Prognostic significance of FA score based on plasma fibrinogen and serum albumin in patients with epithelial ovarian cancer.[J] .Cancer Manag Res, 2019, 11: 7697-7705.
11.Zhang Liwei, Jin Yue, Yang Hao et al. SMYD3 promotes epithelial ovarian cancer metastasis by downregulating p53 protein stability and promoting p53 ubiquitination.[J] .Carcinogenesis, 2019, 40: 1492-1503.
12.Wu B, Yang Z, Tobe R G et al. Medical therapy for preventing recurrent endometriosis after conservative surgery: a cost-effectiveness analysis. [J] .BJOG, 2018, 125: 469-477.
